These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 25439367

  • 1. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
    Patel M, Pilcher J, Reddel HK, Qi V, Mackey B, Tranquilino T, Shaw D, Black P, Weatherall M, Beasley R, SMART Study Group.
    J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367
    [Abstract] [Full Text] [Related]

  • 2. Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.
    Pilcher J, Patel M, Smith A, Davies C, Pritchard A, Travers J, Black P, Weatherall M, Beasley R, Harwood M, SMART Study Group.
    Respirology; 2014 Aug; 19(6):842-51. PubMed ID: 24889937
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M, Pilcher J, Pritchard A, Perrin K, Travers J, Shaw D, Holt S, Harwood M, Black P, Weatherall M, Beasley R, SMART Study Group.
    Lancet Respir Med; 2013 Mar; 1(1):32-42. PubMed ID: 24321802
    [Abstract] [Full Text] [Related]

  • 4. Metrics of salbutamol use as predictors of future adverse outcomes in asthma.
    Patel M, Pilcher J, Reddel HK, Pritchard A, Corin A, Helm C, Tofield C, Shaw D, Black P, Weatherall M, Beasley R, SMART Study Group.
    Clin Exp Allergy; 2013 Oct; 43(10):1144-51. PubMed ID: 24074332
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
    Tunceli O, Williams SA, Kern DM, Elhefni H, Pethick N, Wessman C, Zhou S, Trudo F.
    J Allergy Clin Immunol Pract; 2014 Oct; 2(6):719-26. PubMed ID: 25439363
    [Abstract] [Full Text] [Related]

  • 7. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.
    Curr Med Res Opin; 2004 Oct; 20(2):225-40. PubMed ID: 15006018
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
    Beasley R, Holliday M, Reddel HK, Braithwaite I, Ebmeier S, Hancox RJ, Harrison T, Houghton C, Oldfield K, Papi A, Pavord ID, Williams M, Weatherall M, Novel START Study Team.
    N Engl J Med; 2019 May 23; 380(21):2020-2030. PubMed ID: 31112386
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, Boulet LP, Naya IP, Hultquist C.
    Curr Med Res Opin; 2004 Sep 23; 20(9):1403-18. PubMed ID: 15383189
    [Abstract] [Full Text] [Related]

  • 11. Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.
    Papi A, Mansur AH, Pertseva T, Kaiser K, McIver T, Grothe B, Dissanayake S.
    J Aerosol Med Pulm Drug Deliv; 2016 Aug 23; 29(4):346-61. PubMed ID: 27104231
    [Abstract] [Full Text] [Related]

  • 12. Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD.
    Tashkin DP.
    Expert Rev Respir Med; 2010 Dec 23; 4(6):703-14. PubMed ID: 21128746
    [Abstract] [Full Text] [Related]

  • 13. Real-life use of budesonide/formoterol in clinical practice: a 12-month follow-up assessment in a multi-national study of asthma patients established on single-inhaler maintenance and reliever therapy.
    Ställberg B, Naya I, Ekelund J, Eckerwall G.
    Int J Clin Pharmacol Ther; 2015 Jun 23; 53(6):447-55. PubMed ID: 25907171
    [Abstract] [Full Text] [Related]

  • 14. Effect of smoking status on the efficacy of the SMART regimen in high risk asthma.
    Pilcher J, Patel M, Reddel HK, Pritchard A, Black P, Shaw D, Holt S, Weatherall M, Beasley R.
    Respirology; 2016 Jul 23; 21(5):858-66. PubMed ID: 26897389
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis.
    Patel M, Pilcher J, Hancox RJ, Sheahan D, Pritchard A, Braithwaite I, Shaw D, Black P, Weatherall M, Beasley R, SMART Study Group.
    NPJ Prim Care Respir Med; 2015 Jan 08; 25():14099. PubMed ID: 25569185
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
    Miller E, FitzGerald JM.
    Can J Clin Pharmacol; 2008 Jan 08; 15(2):e165-76. PubMed ID: 18515918
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K.
    Pulm Pharmacol Ther; 2014 Feb 08; 27(1):52-6. PubMed ID: 23583566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.